Showing posts with label Pharmagen Announces Food and Drug Administration Registration. Show all posts
Showing posts with label Pharmagen Announces Food and Drug Administration Registration. Show all posts

Thursday, November 7, 2013

Pharmagen Announces Food and Drug Administration Registration


SILVER SPRING, Md., Nov. 6, 2013 /PRNewswire/ -- Pharmagen, Inc. (PHRX) (the "Company" or "Pharmagen") announces that it has completed the registration of Pharmagen Laboratories with the Food and Drug Administration ("FDA"). Since the tragic fungal meningitis outbreak associated with New England Compounding Center (NECC) in late 2012, Pharmagen recognizes the need for FDA's oversight of the sterile compounding industry. In an effort to embrace the pending changes in compounding pharmacy regulation, Pharmagen's registration with the FDA moves the Company closer to full cGMP compliance – including adherence to Federal Statutes 21 CFR Parts 11, 210, and 211.